Breaking News

NEW YORK, April 27 – Following a trend that is becoming common on Wall Street these days, Packard Bioscience has withdrawn a planned follow-on offering of 10 million shares of its common stock, the company said Friday. This announcement

NEW YORK, April 26, 2001 - PerkinElmer has introduced a new SNP detection method that uses fluorescence polarization, the company said Thursday. This company’s new AcycloPrime FP SNP Detection System is a microplate-

NEW YORK April 26 - IBM and NetGenics said Thursday they have expanded their existing partnership to include an agreement for NetGenics to resell IBM's DiscoveryLink data integration software. The companies began collabo

NEW YORK, April 26 - GeneProt said Thursday it has opened its large-scale proteomic discovery center in Geneva, Switzerland.  "Today we basically established GeneProt's leadership in the role of proteomics," said Cedric Lo

NEW YORK, April 26 - Early-stage assay makers Aclara Biosciences and Illumina both reported slightly higher revenues for the first quarter of 2001, coupled with rises in net losses. Aclara, which manufactures lab-on-a

NEW YORK, April 26 - Celera said Thursday its third-quarter fiscal 2001 revenues rose to $23.4 million, from $11.1 million in the year-ago period, as the company continued to add subscribers to its database and to initiate new collaborations.

NEW YORK, April 26 – Syrrx has appointed Norman Halleen to the position of vice president of finance and chief financial officer, a new position, the company said Thursday. Halleen comes to the company from Aradigm, a maker of drug deli

NEW YORK, April 26 - Atlas Venture has raised $950 million from institutional investors to start a new capital fund that will invest in early-stage communications, information technology, and life science companies, the venture capital firm said Thursday.

NEW YORK, April 26 – Luminex and Lifecodes, a provider of DNA testing services, have agreed to collaborate on the development of pre-transplant tests using Luminex’s LabMap instrumentation, the companies said Thursday. The multi-year pa

NEW YORK, April 25 – Genomic Solutions will fund two researchers at the University of Louisville to develop next generation isoelectric focusing (IEF) technology, the company said Wednesday. The researchers, Jon Klein and Elias

NEW YORK, April 25 - Incyte Genomics earned revenues of $51 million for the first quarter of 2001, up 25 percent from the same period a year ago, the company reported Wednesday. The increase in revenue represents the fourth co

NEW YORK, April 25 – Affymetrix reported a 36 percent increase in first-quarter revenues Wednesday, but said it expected to lose $15 to $25 million in revenues for the year due to its defective mouse arrays. Affymetrix disclose

NEW YORK, April 25 - Biogen has licensed the Rosetta Resolver gene expression analysis system from Rosetta Inpharmatics, the companies said Wednesday. Biogen will use the Resolver system to manage and analyze its gene expression da

NEW YORK, April 25  - Despite a flurry of new collaborations with users of its microbead technology, Lynx Therapeutics reported Wednesday nearly flat first-quarter revenues. Lynx’s revenues increased slightly to $3.4

NEW YORK, April 25 – Hyseq said Wednesday it appointed Peter Garcia as chief financial officer.

NEW YORK, April 25 – The Institute for Genomic Research said Wednesday it has received a grant from the National Institute of Allergy and Infectious Diseases to complete the sequencing of Cryptococcus neoformans , an organism that causes cryptococcosis, a potentia

NEW YORK, April 25 – Dennis Harris, formerly Amersham Pharmacia Biotech’s North American vice president of research & development, has taken a newly created position as senior vice president of R&D at microfluidics-maker Aclara Biosciences, Aclara said Wednesday.

NEW YORK, April 24 - Yamanouchi pharmaceuticals, Japan's third-largest drugmaker, plans to double its commitment to genomics over the next five years to 50 billion yen, or $411.8 million, Reuters reported from Tokyo on Tuesday. The Tokyo-based company, which has invested fou

NEW YORK, April 24 – Micromass has agreed to link its mass spectrometry software applications to Spotfire’s portals, Spotfire said Tuesday.

NEW YORK, April 24 - Pharmaceutical companies must continue incorporating genomics technologies and adapt to the Internet as a management tool if they hope to decrease the costs associated with drug development, consulting firm Accenture said in a report released Tuesday. “Emerging te

NEW YORK, April 24 -  Microbead maker Luminex on Tuesday reported revenues of $3.9 million in the first quarter of 2001, up from $1.4 million in the year-ago quarter and in-line with its recently reduced forecast.

NEW YORK, April 24 - Genaissance Pharmaceuticals said Tuesday it had begun enrolling patients for its clinical trials which will aim to correlate haplotypes with individuals’ reactions to particular drugs. In its initial study, the comp

NEW YORK, April 24 – DoubleTwist announced Tuesday that it had acquired the exclusive rights to commercialize the Weizmann Institute’s GeneCards database, reflecting the company’s efforts to expand its offerings by not only building its own products but also by gainin

NEW YORK, April 24 –Buoyed by sales of seven new MassArray genotyping systems, Sequenom reported a substantial spike in first-quarter 2001 revenues Tuesday, while losses narrowed and beat expectations.

NEW YORK, April 24 – Qiagen has acquired Sawady, a Japanese maker of nucleic acids, in return for $18 million of Qiagen common stock, the companies said Tuesday. The Sawady group of Tokyo, comprises three companies, Sawady Technology, O


The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.